Skip to main content

注意 - ATTENTION

目前仅LUMINEX LTG部分的内容采用中文表达，所有其它内容依旧提供英文版本

Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Chinese.

我们的博客

我们坚信知识就是力量。通过为科学家、研究人员及医疗工作者提供强大工具，助力其实现突破性发现，为患者提供最佳诊疗方案。
本博客作为深度洞见平台，汇聚专业观点与实践应用，全方位展现我们在全球范围内产生的卓越影响力。

xMAP® Connect: Advances in Aging and Dry Eye

xMAP® Connect | xMAP® Multiplexing

 August 3, 2022

xMAP® Connect: Advances in Aging and Dry Eye

Discover more
Scientists Demonstrate Utility of xMAP® Technology for Studying Antibody Binding Kinetics

xMAP® Multiplexing

 

 July 28, 2022

Scientists Demonstrate Utility of xMAP® Technology for Studying Antibody Binding Kinetics

Discover more
xMAP® Connect: Measuring Immune Response for Vaccine Development

xMAP® Connect | xMAP® Multiplexing

 July 6, 2022

xMAP® Connect: Measuring Immune Response for Vaccine Development

Discover more
Multiplexing 101: New Resource for Immunoassays in Biomarker Discovery

xMAP® Multiplexing

 

 July 1, 2022

Multiplexing 101: New Resource for Immunoassays in Biomarker Discovery

Discover more
CDC Scientist Describes Multiplex Testing for Malaria at Immunology2022™

xMAP® Multiplexing

 

 June 24, 2022

CDC Scientist Describes Multiplex Testing for Malaria at Immunology2022™

Discover more
Luminex Licensed Technologies Partner Spotlight: VRL

xMAP® Multiplexing

 

 June 2, 2022

Luminex Licensed Technologies Partner Spotlight: VRL

Discover more
Webinar: How Drug Discovery Scientists Improved Biomarker Evaluation with xMAP® Technology

xMAP® Multiplexing

 

 May 11, 2022

Webinar: How Drug Discovery Scientists Improved Biomarker Evaluation with xMAP® Technology

Discover more
Questions to Ask When Choosing a Multiplex Assay Kit

xMAP® Multiplexing

 

 May 5, 2022

Questions to Ask When Choosing a Multiplex Assay Kit

Discover more
Peer-Reviewed Publications Illustrate Versatility of xMAP® Technology

xMAP® Multiplexing

 

 May 5, 2022

Peer-Reviewed Publications Illustrate Versatility of xMAP® Technology

Discover more